196 related articles for article (PubMed ID: 29971627)
1. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.
Berthe A; Zaffino M; Muller C; Foulquier F; Houdou M; Schulz C; Bost F; De Fay E; Mazerbourg S; Flament S
Breast Cancer Res Treat; 2018 Oct; 171(3):581-591. PubMed ID: 29971627
[TBL] [Abstract][Full Text] [Related]
2. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
Kurtoglu M; Gao N; Shang J; Maher JC; Lehrman MA; Wangpaichitr M; Savaraj N; Lane AN; Lampidis TJ
Mol Cancer Ther; 2007 Nov; 6(11):3049-58. PubMed ID: 18025288
[TBL] [Abstract][Full Text] [Related]
3. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
[TBL] [Abstract][Full Text] [Related]
4. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
Xi H; Kurtoglu M; Liu H; Wangpaichitr M; You M; Liu X; Savaraj N; Lampidis TJ
Cancer Chemother Pharmacol; 2011 Apr; 67(4):899-910. PubMed ID: 20593179
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
[TBL] [Abstract][Full Text] [Related]
7. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
Liu H; Kurtoglu M; Cao Y; Xi H; Kumar R; Axten JM; Lampidis TJ
Cancer Chemother Pharmacol; 2013 Jul; 72(1):251-62. PubMed ID: 23700291
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
[TBL] [Abstract][Full Text] [Related]
9. Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness.
Fujita M; Imadome K; Somasundaram V; Kawanishi M; Karasawa K; Wink DA
BMC Cancer; 2020 Sep; 20(1):929. PubMed ID: 32993545
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
Bhatt AN; Kumar A; Rai Y; Kumari N; Vedagiri D; Harshan KH; Chinnadurai V; Chandna S
Life Sci; 2022 Apr; 295():120411. PubMed ID: 35181310
[TBL] [Abstract][Full Text] [Related]
11. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
[TBL] [Abstract][Full Text] [Related]
12. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
13. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
[TBL] [Abstract][Full Text] [Related]
14. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms.
Laussel C; Léon S
Biochem Pharmacol; 2020 Dec; 182():114213. PubMed ID: 32890467
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment.
Maximchik P; Abdrakhmanov A; Inozemtseva E; Tyurin-Kuzmin PA; Zhivotovsky B; Gogvadze V
FEBS J; 2018 Dec; 285(24):4590-4601. PubMed ID: 30375744
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
Wang P; Shan XH; Xiong F; Gu N; Qian H; Fan Y; Wang YF
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):566-71. PubMed ID: 24314212
[TBL] [Abstract][Full Text] [Related]
18. ATF4 mediates necrosis induced by glucose deprivation and apoptosis induced by 2-deoxyglucose in the same cells.
León-Annicchiarico CL; Ramírez-Peinado S; Domínguez-Villanueva D; Gonsberg A; Lampidis TJ; Muñoz-Pinedo C
FEBS J; 2015 Sep; 282(18):3647-58. PubMed ID: 26172539
[TBL] [Abstract][Full Text] [Related]
19. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].
Giliano NY; Bondarev GN; Konevega LV; Noskin LA; Zhurishkina EV; Alchinova IB
Patol Fiziol Eksp Ter; 2014; (4):78-85. PubMed ID: 25980231
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
